Kronik anal fissür için anal Botulinium toksin enjeksiyonu: 224 hastadan oluşan retrospektif bir kohortta etkinlik ve güvenlik analizi

Year 2023, Volume: 22 Issue: 2, 112 - 118, 31.08.2023

Cengiz Dibekoğlu

https://doi.org/10.17941/agd.1347472

Abstract

Giriş ve Amaç: Anal Botulinium toksin tedavisi uygulanan kronik anal fissürlü hastada enjeksiyon bölgelerinin sayısı ile iyileşme sonuçları arasındaki ilişkiyi değerlendirmektir. Gereç ve Yöntem: Ocak 2012 ve Mart 2023 tarihleri arasında anal Botulinium toksin tedavisi uygulanan 224 hasta kaydı retrospektif olarak analiz edildi. Hastalar enjeksiyon bölgelerinin sayısına göre üç gruba ayrıldı: Grup A (iki enjeksiyon bölgesi, n = 34), Grup B (üç enjeksiyon bölgesi, n = 109) ve Grup C (dört enjeksiyon bölgesi, n = 81). Her enjeksiyonda 20 IU Botulinium toksin uygulanmıştı. İyileşme sonuçları yara iyileşmesi ve semptomların giderilmesi olarak 15, 30 ve 90. günde değerlendirilmiştir. Demografik bilgiler, tedavi ayrıntıları, iyileşme sonuçları ve tedaviye ilişkin olumsuz olaylar kaydedildi. Bulgular: Cox regresyon analizi, enjeksiyon bölgesi sayısı ile iyileşme sonuçları arasında anlamlı bir ilişki olduğunu ortaya koydu. Ameliyat sonrası her üç zaman noktasında da, ikiden fazla bölgede tedavi edilen hastalar (Grup C), iki bölgede tedavi edilen hastalara (Grup A) kıyasla daha yüksek iyileşme seviyeleri bildirmiştir. Sonuç: Kronik anal fissürü olan hastalarda anal Botulinium toksin ile tedavi edilen enjeksiyon bölgelerinin sayısı ile iyileşme sonuçları arasında ilişki vardır. Enjeksiyon bölgelerinin sayısının artması hem yara iyileşmesini hem de semptomların azalmasını arttırmaktadır.

Keywords

Enjeksiyon bölgesi sayıları, anal fissür, Botulinium toksini

Anal Botulinium toxin injection for chronic anal fissure: Efficacy and safety analysis in a retrospective cohort of 224 patients

Abstract

Backgorund and Aims: The aim of this retrospective study is to evaluate the relationship between the number of injection sites and healing outcomes in 224 patients with chronic anal fissure who underwent anal Botulinum toxin treatment. Materials and Methods: The medical records of 224 patients who received anal Botulinum toxin treatment for chronic anal fissure were retrospectively analyzed. Patients were categorized into three groups based on the number of injection sites: Group A (two injection sites, n = 34), Group B (three injection sites, n = 109), and Group C (four injection sites, n = 81). Each injection contains 20 IU of Botulinum toxin. Healing outcomes, pain reduction, wound healing, and symptom resolution were evaluated. A comprehensive analysis of patient records and clinical data was performed. Demographic information, treatment details, healing outcomes, and adverse events were assessed. Results: Cox regression analysis revealed a significant association between the number of injection sites and healing outcomes. At all three post-operative time points, patients treated at multiple sites (Group C) reported higher recovery levels compared to patients treated at two sites (Group A). Conclusion: This study demonstrated a significant relationship between the number of injection sites treated with anal Botulinum toxin and healing outcomes in patients with chronic anal fissures. These findings highlight the importance of considering the number of injection sites. The study contributes to the understanding of anal Botulinum toxin treatment for chronic anal fissure, emphasizing its potential to improve patient care and overall quality of life.

Keywords

Botulinum toxin, anal fissure, injection site numbers, healing

References

• 1. Bobkiewicz A, Francuzik W, Krokowicz L, et al. Botulinum toxin injection for treatment of chronic anal fissure: Is there any dose-dependent efficiency? A Meta-Analysis. World J Surg 2016;40:3064-72.
• 2. Jin JZ, Bhat S, Park B, et al. A systematic review and network meta-analysis comparing treatments for anal fissure. Surgery 2022;172:41-52.
• 3. Beaty JS, Shashidharan M. Anal fissure. Clin Colon Rectal Surg 2016;29:30-7.
• 4. Casillas S, Hull TL, Zutshi M, et al. Incontinence after a lateral internal sphincterotomy: are we underestimating it? Dis Colon Rectum 2005;48:1193-9.
• 5. D'Orazio B, Geraci G, Martorana G, et al. Fisurectomy and anoplasty with botulinum toxin injection in patients with chronic anal posterior fissure with hypertonia: a long-term evaluation. Updates Surg 2021;73:1575-81.
• 6. Dat A, Chin M, Skinner S, et al. Botulinum toxin therapy for chronic anal fissures: where are we at currently? ANZ J Surg 2017;87:E70-E73.
• 7. Borsuk DJ, Studniarek A, Park JJ, et al. Use of Botulinum Toxin Injections for the Treatment of Chronic Anal Fissure: Results From an American Society of Colon and Rectal Surgeons Survey. Am Surg 2023;89:346-54.
• 8. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993;36:77-97.
• 9. Barbeiro S, Atalaia-Martins C, Marcos P, et al. Long-term outcomes of Botulinum toxin in the treatment of chronic anal fissure: 5 years of follow-up. United European Gastroenterol J 2017;5:293-7.
• 10. Dokucu Ş, Başçeken Sİ. Botulinum toxin injection in outpatients for chronic anal fissure. Acta Chir Belg 2023;14:1-6.
• 11. Yiannakopoulou, E. Botulinum toxin and anal fissure: Efficacy and safety systematic review. Int J Colorectal Dis 2012;27:1-9.
• 12. Brisinda G, Maria G, Bentivoglio AR. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999;341:65-9.
• 13. Vitoopinyoparb K, Insin P, Thadanipon K, et al. Comparison of doses and injection sites of botulinum toxin for chronic anal fissure: A systematic review and network meta-analysis of randomized controlled trials. Int J Surg 2022;104:106798.
• 14. Ravindran P, Chan DL, Ciampa C, et al. High-dose versus low-dose botulinum toxin in anal fissure disease. Tech Coloproctol 2017;21:803-8.
• 15. Cakir C, Idiz UO, Aydin I, et al. Comparison of the effectiveness of two treatment modalities for chronic anal fissure: Botox versus sphincterotomy. Turk J Surg 2020;36:264-70.
• 16. D'Orazio B, Geraci G, Bonventre S, Calì D, Di Vita G. Safety and effectiveness of saving sphincter procedure in the treatment of chronic anal fissure in female patients. BMC Surg 2021;21:350.
• 17. Brisinda G, Maria G, Sganga G, et al. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery 2002;131:179-84.
• 18. Sultan AH, Kamm MA, Nicholls RJ, Bartram CI. Prospective study of the extent of internal anal sphincter division during lateral sphincterotomy. Dis Colon Rectum 1994;37:1031-3.